Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. | Blood | 2022 | 34582559 | PubTator, text mining | PubMed |
| Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. | Blood Adv | 2022 | 34551064 | PubTator, text mining | PubMed |
| Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis. | FEBS J | 2022 | 34482632 | PubTator, text mining | PubMed |
| A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells. | Cell Chem Biol | 2022 | 34469831 | PubTator, text mining | PubMed |
| YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. | Leukemia | 2022 | 34465866 | PubTator, text mining | PubMed |
| The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis. | Leukemia | 2022 | 34321607 | PubTator, text mining | PubMed |
| Nuclear Protein Condensates and Their Properties in Regulation of Gene Expression. | J Mol Biol | 2022 | 34271007 | PubTator, text mining | PubMed |
| The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer. | J Mol Biol | 2022 | 34174329 | PubTator, text mining | PubMed |
| Gene expression profiles of breast cancer metastasis according to organ site. | Mol Oncol | 2022 | 34051058 | PubTator, text mining | PubMed |
| How Protein Methylation Regulates Steroid Receptor Function. | Endocr Rev | 2022 | 33955470 | PubTator, text mining | PubMed |
| Epigenome-wide analysis of long-term air pollution exposure and DNA methylation in monocytes: results from the Multi-Ethnic Study of Atherosclerosis. | Epigenetics | 2022 | 33818294 | PubTator, text mining | PubMed |
| Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma. | Haematologica | 2022 | 33440923 | PubTator, text mining | PubMed |
| Targeting epigenetic regulatory machinery to overcome cancer therapy resistance. | Semin Cancer Biol | 2022 | 33421619 | PubTator, text mining | PubMed |
| Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis. | Haematologica | 2022 | 33375773 | PubTator, text mining | PubMed |
| Profiling epigenetic age in single cells. | Nat Aging | 2021 | 36211119 | PubTator, text mining | PubMed |
| The Cell as Matter: Connecting Molecular Biology to Cellular Functions. | Matter | 2021 | 35495565 | PubTator, text mining | PubMed |
| O-GlcNAcylation links oncogenic signals and cancer epigenetics. | Discov Oncol | 2021 | 35201498 | PubTator, text mining | PubMed |
| Oral cancer diagnostics: An overview. | Natl J Maxillofac Surg | 2021 | 35153426 | PubTator, text mining | PubMed |
| Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia. | Front Oncol | 2021 | 35127484 | PubTator, text mining | PubMed |
| RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity. | Nat Cancer | 2021 | 35121884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=52